HN
Hemanshu Nitinchandra Pandya
About Hemanshu Nitinchandra Pandya
Data last updated:
Hemanshu Nitinchandra Pandya is a Director at Senores Pharmaceuticals Limited (since 2023). The company operates in Pharma. Senores Pharmaceuticals Limited reported revenue of ₹418 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Nov 2023 | 2017 | ₹418 Cr (FY 2025) | Active |
Board colleagues of Hemanshu Nitinchandra Pandya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arpit Deepakkumar Shah | 07214641 | Senores Pharmaceuticals Limited | Director |
| Ashokkumar Vijaysinh Barot | 01192300 | Senores Pharmaceuticals Limited | Director |
| Chetan Bipinchandra Shah | 10381971 | Senores Pharmaceuticals Limited | Whole-Time Director |
| Deval Rajnikant Shah | 00332722 | Senores Pharmaceuticals Limited | Whole-Time Director |
| Deval Rajnikant Shah | Senores Pharmaceuticals Limited | Cfo | |
| Jitendra Babulal Sanghvi | 00271995 | Senores Pharmaceuticals Limited | Director |
| Kalpit Rajesh Gandhi | 02843308 | Senores Pharmaceuticals Limited | Director |
| Manjula Devi Shroff | 00297159 | Senores Pharmaceuticals Limited | Director |
| Naresh Bansilal Shah | 10384306 | Senores Pharmaceuticals Limited | Director |
| Sanjay Shaileshbhai Majmudar | 00091305 | Senores Pharmaceuticals Limited | Director |
| Swapnil Jatinbhai Shah | 05259821 | Senores Pharmaceuticals Limited | Managing Director |
| Udayan Dileep Choksi | 02222020 | Senores Pharmaceuticals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemanshu Nitinchandra Pandya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemanshu Nitinchandra Pandya
Hemanshu Nitinchandra Pandya currently holds 1 directorship: Senores Pharmaceuticals Limited (Director, since 10 Nov 2023, revenue ₹418 Cr (FY 2025)).
Hemanshu Nitinchandra Pandya was first appointed on 10 Nov 2023 as Director at Senores Pharmaceuticals Limited.
The current boards of Hemanshu Nitinchandra Pandya's companies include Arpit Deepakkumar Shah (Senores Pharmaceuticals Limited), Ashokkumar Vijaysinh Barot (Senores Pharmaceuticals Limited), Chetan Bipinchandra Shah (Senores Pharmaceuticals Limited), Deval Rajnikant Shah (Senores Pharmaceuticals Limited), Deval Rajnikant Shah (Senores Pharmaceuticals Limited), Jitendra Babulal Sanghvi (Senores Pharmaceuticals Limited), among others.